Civic Intelligence

Frontiers in Bioscience Inc.

990 • Fiscal year 2013 • EIN 59-3432665

Jan 01, 2013 to Dec 31, 2013 • Filed on May 13, 2014

20 Sunset CoveNewport Coast, CA 92657

(949) 715-8286

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

21st percentile

0.02x

Higher debt load relative to assets than 21% of similar nonprofits.

2013 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2013

Liabilities / Revenue

45th percentile

0.16x

Higher debt load relative to revenue than 45% of similar nonprofits.

2013 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2013

Net Margin

88th percentile

42%

Higher net margin than 88% of similar nonprofits.

2013 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2013

Top Officer Pay

44th percentile

$95,941

Higher top officer pay than 44% of similar nonprofits.

Top officer pay equals 9.4% of source-year revenue.

2013 filings • 501(c)3 • $5M-$10M nonprofits • Source year 2013

Asset Growth

62nd percentile

6.5%

Faster asset growth than 62% of similar nonprofits.

2013 filings • 501(c)3 • $5M-$10M nonprofits • Annualized from 2012 to 2013

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2013

Assets

Up

$7,019,430

Up $425,728 (+6.5%) from 2012

Net Assets

Up

$6,861,137

Up $428,702 (+6.7%) from 2012

Liabilities

Down

$158,293

Down $2,974 (-1.8%) from 2012

Revenue

$1,020,368

No earlier filing loaded for comparison.

Expenses

Up

$591,666

Up $24,792 (+4.4%) from 2012

Net Income

$428,702

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$10M$5.0M$0Assets 2011: $6,072,390Liabilities 2011: $145,555Net Assets 2011: $5,926,8352011Assets 2012: $6,593,702Liabilities 2012: $161,267Net Assets 2012: $6,432,4352012Assets 2013: $7,019,430Liabilities 2013: $158,293Net Assets 2013: $6,861,1372013Assets 2014: $7,380,585Liabilities 2014: $279,146Net Assets 2014: $7,101,4392014Assets 2015: $7,717,237Liabilities 2015: $161,947Net Assets 2015: $7,555,2902015Assets 2016: $7,719,461Liabilities 2016: $139,799Net Assets 2016: $7,579,6622016Assets 2017: $7,939,484Liabilities 2017: $38,338Net Assets 2017: $7,901,1462017Assets 2018: $8,152,585Liabilities 2018: $31,140Net Assets 2018: $8,121,4452018Assets 2019: $8,329,196Liabilities 2019: $28,843Net Assets 2019: $8,300,3532019Assets 2020: $9,154,107Liabilities 2020: $192,253Net Assets 2020: $8,961,8542020Assets 2021: $9,263,668Liabilities 2021: $187,520Net Assets 2021: $9,076,1482021Assets 2022: $9,068,473Liabilities 2022: $175,870Net Assets 2022: $8,892,6032022Assets 2023: $9,132,862Liabilities 2023: $252,072Net Assets 2023: $8,880,7902023Assets 2024: $9,147,259Liabilities 2024: $244,048Net Assets 2024: $8,903,2112024Assets 2025: $8,977,418Liabilities 2025: $246,462Net Assets 2025: $8,730,9562025

Highlighted filing

2013

Assets$7,019,430
Liabilities$158,293
Net Assets$6,861,137

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$1.5M$1.0M$500K$0-$500KExpenses 2011: $303,3232011Expenses 2012: $566,8742012Revenue 2013: $1,020,368Expenses 2013: $591,666Net Income 2013: $428,7022013Revenue 2014: $929,379Expenses 2014: $583,280Net Income 2014: $346,0992014Revenue 2015: $959,466Expenses 2015: $568,606Net Income 2015: $390,8602015Revenue 2016: $686,860Expenses 2016: $662,488Net Income 2016: $24,3722016Revenue 2017: $884,845Expenses 2017: $563,361Net Income 2017: $321,4842017Revenue 2018: $687,687Expenses 2018: $467,385Net Income 2018: $220,3022018Revenue 2019: $665,550Expenses 2019: $464,587Net Income 2019: $200,9632019Revenue 2020: $1,172,136Expenses 2020: $303,230Net Income 2020: $868,9062020Revenue 2021: $287,321Expenses 2021: $239,359Net Income 2021: $47,9622021Revenue 2022: $130,196Expenses 2022: $272,103Net Income 2022: -$141,9072022Revenue 2023: $252,831Expenses 2023: $264,644Net Income 2023: -$11,8132023Revenue 2024: $159,183Expenses 2024: $334,551Net Income 2024: -$175,3682024Revenue 2025: $179,746Expenses 2025: $394,681Net Income 2025: -$214,9352025

Highlighted filing

2013

Revenue$1,020,368
Expenses$591,666
Net Income$428,702
Jump To
Filing Snapshot
Filing Period
Jan 1, 2013 to Dec 31, 2013
Signed
May 13, 2014
Return Version
2013v3.1
Gross Receipts
$1,020,368
Mission and Program Overview

Mission

Frontiers in bioscience ia an organizatioj dedicated to fostering science, research and teaching. Fbs has been invo;ve in these activities since jan. 1 1996. Fbs has published ober 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and reurranxce as well as understanding the cause of disturbed metabolism of cancer cells in order to gain an insight to provide new avenues for treatment. We use stem cells as well as signaling molecules to acheive the therapeutic end.

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or dece

Balance Sheet Detail
LineBeginningEndChange
Assets
Cash and Non-Interest-Bearing Accounts$3,384,005$3,979,922▲ $595,917
Land, Buildings, and Equipment, Net$3,105,037$3,021,707▼ $83,330
Loans From Officers Directors$145,555$145,555→ $0
Other Notes and Loans Receivable, Net$100,000$13,141▼ $86,859
Investments in Publicly Traded Securities$4,660$4,660→ $0
Total Assets$6,593,702$7,019,430▲ $425,728
Liabilities
Accounts Payable and Accrued Expenses$15,712$12,738▼ $2,974
Total Liabilities$161,267$158,293▼ $2,974
Net Assets / Fund Balance
Unrestricted Net Assets$6,432,435$6,861,137▲ $428,702
Total Net Assets Fund Balance$6,432,435$6,861,137▲ $428,702
Total Liabilities and Net Assets / Fund Balance$6,593,702$7,019,430▲ $425,728

Asset Categories

AssetBook ValueDepreciationBasis
Buildings$1,294,001$141,314$853,485
Land$1,630,474-$374,293
Equipment$74,793$222,254$297,047
Other Land Buildings$22,439$33,270$55,709
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
Siamak Tabibzadeh MdPresident/ceFT$80,000$15,941$95,941
Daniel TabibzadehSecretaryPT$23,538-$23,538

Board Members and Trustees

NameTitle
Bruce HoumanDirector
Masood KashanchiDirector
Jennifer TabibzadehTreasurer/cf
Revenue and Support

Revenue Composition

Contributions and Grants
$0
Program Service Revenue
$1,012,822
Investment Income
$7,546
Other Revenue
$0
Change in Net Assets
$428,702
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$301,628
Salaries, Compensation, and Employee Benefits$290,038
Total Fundraising Expense$10,584
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Other Salaries and Wages$150,754--$150,754
Current Officers, Directors, Trustees, and Key Employees$64,000$31,538$8,000$103,538
Depreciation Depletion$69,516--$69,516
All Other Expenses$32,652--$32,652
Occupancy$23,668--$23,668
Payroll Taxes$14,854$3,961$990$19,805
Other Employee Benefits$12,753$1,594$1,594$15,941
Other Expenses$13,610--$13,610
Office Expenses$11,821--$11,821
Fees for Services Accounting-$7,200-$7,200
Fees for Services Other$6,820--$6,820
Travel$4,462--$4,462
Insurance$3,897--$3,897
Fees for Services Legal-$3,834-$3,834
Information Technology$764--$764
Conferences and Meetings$297--$297
Total Functional Expenses$532,955$48,127$10,584$591,666
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Interested-Person Transactions

Interested PartyRelationshipDescriptionShared RevenueAmount
Siamak TabibzadehCEOSalary Executive DirNo$80,000
Daniel TabibzadehSecretarySalary Admin DirNo$23,538

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$145,555$145,555→ $0
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
No
Business relationship with family members
Yes
Business relationship with organization members
Yes
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 2

Siamak tabibzadeh daniel tabibzadeh presidentceo secretary father/son siamak tabibzadeh jennifer tabibzadeh presidentceo director father/daughter

Form 990, Page 6, Part VI, Line 11B

The form 990 is reviewed with the cpa consultant as to accuracy and completeness.

Form 990, Page 6, Part VI, Line 19

AVAIABLE UPON REQUEST.

Filing and Contact Details

Filer

EIN
59-3432665
Phone
9497158286

Signing Officer

Name
Siamak Tabibzadeh Md
Title
President
Phone
9497158286
Signed
2014-05-13

Organization Details

Principal Officer
Siamak Tabibzadeh
Formed
1995
Legal Domicile
Fl
Voting Board Members
5
Independent Board Members
2
Employees
6

Preparer

Preparer
Ardavan Keyhan CPA
Phone
9496541400
Supplemental Narrative

Additional Explanations

FORM 990 - ORGANIZATION'S MISSION

Frontiers in bioscience is an organization dedicated to fostering science, research and teaching. Fbs has been involved in these activities since jan 1 1996. Fbs has published over 4000 scholarly scientific articles in medicine and biology from well known scientists. Fbs also carries research in understanding cancer since 2007 and has been working on aging reversal since 2011. Our research on cancer is geared towards understanding the reason for cancer growth and recurrence as well as understanding the cause of disturbed metabolism (warburg's effect) of cancer cells. Such an insight is significant since it provides us with new avenues for treatment of cancer or cancer cure. The treatment of cancer based, on our hypothesis, is founded on new non-chemotherapeutic and non-radiotherpay approaches. We also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.

Form 990, Page 2, Part III, Line 4A

Also examine the cause of senescence, as well as approaches for reversal or deceleration of this process. Based on such a background, we will examine whether senescence can be reversed or decelarated in animal modes before they can be adopted in humans. We will use stem cells as well signaling molecules to achieve such therapeutic end. We hope that our findings will help humanity in a grand scale.

Raw XML Appendix383 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0false
IRS990/AccountsPayableAccrExpnssGrp/BOYAmt015712
IRS990/AccountsPayableAccrExpnssGrp/EOYAmt012738
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE
IRS990/AllOtherExpensesGrp/ProgramServicesAmt032652
IRS990/AllOtherExpensesGrp/TotalAmt032652
IRS990/BooksInCareOfDetail/PersonNm0SIAMAK TABIBZADEH MD
IRS990/BooksInCareOfDetail/PhoneNum09497158286
IRS990/BooksInCareOfDetail/USAddress/AddressLine1020 SUNSET COVE
IRS990/BooksInCareOfDetail/USAddress/City0NEWPORT COAST
IRS990/BooksInCareOfDetail/USAddress/State0CA
IRS990/BooksInCareOfDetail/USAddress/ZIPCode092657
IRS990/BusinessRlnWithFamMemInd0true
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0true
IRS990/CashNonInterestBearingGrp/BOYAmt03384005
IRS990/CashNonInterestBearingGrp/EOYAmt03979922
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompCurrentOfcrDirectorsGrp/FundraisingAmt08000
IRS990/CompCurrentOfcrDirectorsGrp/ManagementAndGeneralAmt031538
IRS990/CompCurrentOfcrDirectorsGrp/ProgramServicesAmt064000
IRS990/CompCurrentOfcrDirectorsGrp/TotalAmt0103538
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConferencesMeetingsGrp/ProgramServicesAmt0297
IRS990/ConferencesMeetingsGrp/TotalAmt0297
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt00
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt07546
IRS990/CYOtherExpensesAmt0301628
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt01012822
IRS990/CYRevenuesLessExpensesAmt0428702
IRS990/CYSalariesCompEmpBnftPaidAmt0290038
IRS990/CYTotalExpensesAmt0591666
IRS990/CYTotalFundraisingExpenseAmt010584
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt01020368
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/DepreciationDepletionGrp/ProgramServicesAmt069516
IRS990/DepreciationDepletionGrp/TotalAmt069516
IRS990/Desc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt06
IRS990/EmploymentTaxReturnsFiledInd0false
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/ExpenseAmt0532955
IRS990/FamilyOrBusinessRlnInd0true
IRS990/FederalGrantAuditRequiredInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt07200
IRS990/FeesForServicesAccountingGrp/TotalAmt07200
IRS990/FeesForServicesLegalGrp/ManagementAndGeneralAmt03834
IRS990/FeesForServicesLegalGrp/TotalAmt03834
IRS990/FeesForServicesOtherGrp/ProgramServicesAmt06820
IRS990/FeesForServicesOtherGrp/TotalAmt06820
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form8282PropertyDisposedOfInd0false
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt040.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt120.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt25.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt35.00
IRS990/Form990PartVIISectionAGrp/AverageHoursPerWeekRt45.00
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd0X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd1X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd2X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd3X
IRS990/Form990PartVIISectionAGrp/IndividualTrusteeOrDirectorInd4X
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OfficerInd1X
IRS990/Form990PartVIISectionAGrp/OfficerInd2X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt015941
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt10
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt20
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt30
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt40
IRS990/Form990PartVIISectionAGrp/PersonNm0SIAMAK TABIBZADEH MD
IRS990/Form990PartVIISectionAGrp/PersonNm1DANIEL TABIBZADEH
IRS990/Form990PartVIISectionAGrp/PersonNm2JENNIFER TABIBZADEH
IRS990/Form990PartVIISectionAGrp/PersonNm3BRUCE HOUMAN
IRS990/Form990PartVIISectionAGrp/PersonNm4MASOOD KASHANCHI
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt080000
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt123538
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt40
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt10
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt20
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt30
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt40
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT/CE
IRS990/Form990PartVIISectionAGrp/TitleTxt1SECRETARY
IRS990/Form990PartVIISectionAGrp/TitleTxt2TREASURER/CF
IRS990/Form990PartVIISectionAGrp/TitleTxt3DIRECTOR
IRS990/Form990PartVIISectionAGrp/TitleTxt4DIRECTOR
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr01995
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt05
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt01020368
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt02
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InformationTechnologyGrp/ProgramServicesAmt0764
IRS990/InformationTechnologyGrp/TotalAmt0764
IRS990/InsuranceGrp/ProgramServicesAmt03897
IRS990/InsuranceGrp/TotalAmt03897
IRS990/InvestmentIncomeGrp/ExclusionAmt07546
IRS990/InvestmentIncomeGrp/TotalRevenueColumnAmt07546
IRS990/InvestmentInJointVentureInd0false
IRS990/InvestmentsPubTradedSecGrp/BOYAmt04660
IRS990/InvestmentsPubTradedSecGrp/EOYAmt04660
IRS990/IRPDocumentCnt07
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt0396838
IRS990/LandBldgEquipBasisNetGrp/BOYAmt03105037
IRS990/LandBldgEquipBasisNetGrp/EOYAmt03021707
IRS990/LandBldgEquipCostOrOtherBssAmt03418545
IRS990/LegalDomicileStateCd0FL
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt0145555
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt0145555
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingAccrualInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECE
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt06432435
IRS990/NetAssetsOrFundBalancesEOYAmt06861137
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ProgramServicesAmt023668
IRS990/OccupancyGrp/TotalAmt023668
IRS990/OfficeExpensesGrp/ProgramServicesAmt011821
IRS990/OfficeExpensesGrp/TotalAmt011821
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrganizationFollowsSFAS117Ind0X
IRS990/OtherEmployeeBenefitsGrp/FundraisingAmt01594
IRS990/OtherEmployeeBenefitsGrp/ManagementAndGeneralAmt01594
IRS990/OtherEmployeeBenefitsGrp/ProgramServicesAmt012753
IRS990/OtherEmployeeBenefitsGrp/TotalAmt015941
IRS990/OtherExpensesGrp/Desc0LABORATORY SUPPLIES/FEES
IRS990/OtherExpensesGrp/Desc1PROPERTY TAXES
IRS990/OtherExpensesGrp/Desc2EVENTS
IRS990/OtherExpensesGrp/Desc320 SUNSET COVE - BUILDING
IRS990/OtherExpensesGrp/ProgramServicesAmt060067
IRS990/OtherExpensesGrp/ProgramServicesAmt145752
IRS990/OtherExpensesGrp/ProgramServicesAmt217268
IRS990/OtherExpensesGrp/ProgramServicesAmt313610
IRS990/OtherExpensesGrp/TotalAmt060067
IRS990/OtherExpensesGrp/TotalAmt145752
IRS990/OtherExpensesGrp/TotalAmt217268
IRS990/OtherExpensesGrp/TotalAmt313610
IRS990/OtherSalariesAndWagesGrp/ProgramServicesAmt0150754
IRS990/OtherSalariesAndWagesGrp/TotalAmt0150754
IRS990/OthNotesLoansReceivableNetGrp/BOYAmt0100000
IRS990/OthNotesLoansReceivableNetGrp/EOYAmt013141
IRS990/PartialLiquidationInd0false
IRS990/PayPremiumsPrsnlBnftCntrctInd0false
IRS990/PayrollTaxesGrp/FundraisingAmt0990
IRS990/PayrollTaxesGrp/ManagementAndGeneralAmt03961
IRS990/PayrollTaxesGrp/ProgramServicesAmt014854
IRS990/PayrollTaxesGrp/TotalAmt019805
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0SIAMAK TABIBZADEH
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgramServiceRevenueGrp/Desc0CHECKS/WIRES-UNIVERSITIES
IRS990/ProgramServiceRevenueGrp/RelatedOrExemptFuncIncomeAmt01012822
IRS990/ProgramServiceRevenueGrp/TotalRevenueColumnAmt01012822
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYExcessBenefitTransInd0false
IRS990/PYInvestmentIncomeAmt012028
IRS990/PYOtherExpensesAmt0404363
IRS990/PYProgramServiceRevenueAmt01060446
IRS990/PYRevenuesLessExpensesAmt0505600
IRS990/PYSalariesCompEmpBnftPaidAmt0162511
IRS990/PYTotalExpensesAmt0566874
IRS990/PYTotalRevenueAmt01072474
IRS990/QuidProQuoContributionsInd0false
IRS990/RcvFndsToPayPrsnlBnftCntrctInd0false
IRS990/ReconcilationRevenueExpnssAmt0428702
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt07546
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt012028
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus2YearsAmt014686
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus3YearsAmt017603
IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus4YearsAmt053569
IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt0105432
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt01012822
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt01060446
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt01246544
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt0889590
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt0830688
IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt05040090
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt07546
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt012028
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus2YearsAmt014686
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus3YearsAmt017603
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus4YearsAmt053569
IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt0105432
IRS990ScheduleA/InvestmentIncomeCYPct00.02000
IRS990ScheduleA/InvestmentIncomePYPct00.03000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct00.97950
IRS990ScheduleA/PublicSupportPY509Pct00.97410
IRS990ScheduleA/PublicSupportTotal509Amt05040090
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt01012822
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt01060446
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt01246544
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt0889590
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt0830688
IRS990ScheduleA/Total509Grp/TotalAmt05040090
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt01020368
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt01072474
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt01261230
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt0907193
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt0884257
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt05145522
IRS990/ScheduleBRequiredInd0false
IRS990ScheduleD/BuildingsGrp/BookValueAmt01294001
IRS990ScheduleD/BuildingsGrp/DepreciationAmt0141314
IRS990ScheduleD/BuildingsGrp/InvestmentCostOrOtherBasisAmt0581830
IRS990ScheduleD/BuildingsGrp/OtherCostOrOtherBasisAmt0853485
IRS990ScheduleD/EquipmentGrp/BookValueAmt074793
IRS990ScheduleD/EquipmentGrp/DepreciationAmt0222254
IRS990ScheduleD/EquipmentGrp/OtherCostOrOtherBasisAmt0297047
IRS990ScheduleD/LandGrp/BookValueAmt01630474
IRS990ScheduleD/LandGrp/InvestmentCostOrOtherBasisAmt01256181
IRS990ScheduleD/LandGrp/OtherCostOrOtherBasisAmt0374293
IRS990ScheduleD/OtherLandBuildingsGrp/BookValueAmt022439
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt033270
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt055709
IRS990ScheduleD/TotalBookValueLandBuildingsAmt03021707
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm0SIAMAK TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/NameOfInterested/PersonNm1DANIEL TABIBZADEH
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt0CEO
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/RelationshipDescriptionTxt1SECRETARY
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd0false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/SharingOfRevenuesInd1false
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt080000
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionAmt123538
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc0SALARY EXECUTIVE DIR
IRS990ScheduleL/BusTrInvolveInterestedPrsnGrp/TransactionDesc1SALARY ADMIN DIR
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt0145555
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0154000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0SIAMAK TABIBZADEH PROMISSORY NOTE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0CEO
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/SupplementalInformationDetail/ExplanationTxt0PERSONAL LOAN TO PURCHASE ASSETS
IRS990ScheduleL/SupplementalInformationDetail/FormAndLineReferenceDesc0SCHEDULE L, PART V
IRS990ScheduleL/TotalBalanceDueAmt0145555
IRS990/ScheduleORequiredInd0true
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0FRONTIERS IN BIOSCIENCE IS AN ORGANIZATION DEDICATED TO FOSTERING SCIENCE, RESEARCH AND TEACHING. FBS HAS BEEN INVOLVED IN THESE ACTIVITIES SINCE JAN 1 1996. FBS HAS PUBLISHED OVER 4000 SCHOLARLY SCIENTIFIC ARTICLES IN MEDICINE AND BIOLOGY FROM WELL KNOWN SCIENTISTS. FBS ALSO CARRIES RESEARCH IN UNDERSTANDING CANCER SINCE 2007 AND HAS BEEN WORKING ON AGING REVERSAL SINCE 2011. OUR RESEARCH ON CANCER IS GEARED TOWARDS UNDERSTANDING THE REASON FOR CANCER GROWTH AND RECURRENCE AS WELL AS UNDERSTANDING THE CAUSE OF DISTURBED METABOLISM (WARBURG'S EFFECT) OF CANCER CELLS. SUCH AN INSIGHT IS SIGNIFICANT SINCE IT PROVIDES US WITH NEW AVENUES FOR TREATMENT OF CANCER OR CANCER CURE. THE TREATMENT OF CANCER BASED, ON OUR HYPOTHESIS, IS FOUNDED ON NEW NON-CHEMOTHERAPEUTIC AND NON-RADIOTHERPAY APPROACHES. WE ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1ALSO EXAMINE THE CAUSE OF SENESCENCE, AS WELL AS APPROACHES FOR REVERSAL OR DECELERATION OF THIS PROCESS. BASED ON SUCH A BACKGROUND, WE WILL EXAMINE WHETHER SENESCENCE CAN BE REVERSED OR DECELARATED IN ANIMAL MODES BEFORE THEY CAN BE ADOPTED IN HUMANS. WE WILL USE STEM CELLS AS WELL SIGNALING MOLECULES TO ACHIEVE SUCH THERAPEUTIC END. WE HOPE THAT OUR FINDINGS WILL HELP HUMANITY IN A GRAND SCALE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2SIAMAK TABIBZADEH DANIEL TABIBZADEH PRESIDENTCEO SECRETARY FATHER/SON SIAMAK TABIBZADEH JENNIFER TABIBZADEH PRESIDENTCEO DIRECTOR FATHER/DAUGHTER
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE FORM 990 IS REVIEWED WITH THE CPA CONSULTANT AS TO ACCURACY AND COMPLETENESS.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt4AVAIABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990 - ORGANIZATION'S MISSION
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 2, PART III, LINE 4A
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 2
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc4FORM 990, PAGE 6, PART VI, LINE 19
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0CA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsBOYAmt06593702
IRS990/TotalAssetsEOYAmt07019430
IRS990/TotalAssetsGrp/BOYAmt06593702
IRS990/TotalAssetsGrp/EOYAmt07019430
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalEmployeeCnt06
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt010584
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt048127
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt0532955
IRS990/TotalFunctionalExpensesGrp/TotalAmt0591666
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt0161267
IRS990/TotalLiabilitiesEOYAmt0158293
IRS990/TotalLiabilitiesGrp/BOYAmt0161267
IRS990/TotalLiabilitiesGrp/EOYAmt0158293
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt06432435
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt06861137
IRS990/TotalOtherCompensationAmt015941
IRS990/TotalProgramServiceExpensesAmt0532955
IRS990/TotalProgramServiceRevenueAmt01012822
IRS990/TotalReportableCompFromOrgAmt0103538
IRS990/TotalRevenueGrp/ExclusionAmt07546
IRS990/TotalRevenueGrp/RelatedOrExemptFuncIncomeAmt01012822
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt01020368
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt06593702
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt07019430
IRS990/TravelGrp/ProgramServicesAmt04462
IRS990/TravelGrp/TotalAmt04462
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UnrestrictedNetAssetsGrp/BOYAmt06432435
IRS990/UnrestrictedNetAssetsGrp/EOYAmt06861137
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1020 SUNSET COVE
IRS990/USAddress/City0NEWPORT COAST
IRS990/USAddress/State0CA
IRS990/USAddress/ZIPCode092657
IRS990/VotingMembersGoverningBodyCnt05
IRS990/VotingMembersIndependentCnt02
IRS990/WebsiteAddressTxt0WWW.BIOSCIENCE.ORG
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02015-11-30 17:44:51Z
ReturnHeader/BusinessOfficerGrp/PersonNm0SIAMAK TABIBZADEH MD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum09497158286
ReturnHeader/BusinessOfficerGrp/SignatureDt02014-05-13
ReturnHeader/Filer/BusinessName/BusinessNameLine10FRONTIERS IN BIOSCIENCE
ReturnHeader/Filer/BusinessNameControlTxt0FRON
ReturnHeader/Filer/EIN0593432665
ReturnHeader/Filer/PhoneNum09497158286
ReturnHeader/Filer/USAddress/AddressLine1020 SUNSET COVE
ReturnHeader/Filer/USAddress/City0NEWPORT COAST
ReturnHeader/Filer/USAddress/State0CA
ReturnHeader/Filer/USAddress/ZIPCode092657
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine10INVISIBLE ACCOUNTANTAN ACCOUNTANCY CORP
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine108001 IRVINE CENTER DR SUITE 970
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/City0IRVINE
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/State0CA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCode092618
ReturnHeader/PreparerPersonGrp/PhoneNum09496541400
ReturnHeader/PreparerPersonGrp/PreparationDt02014-05-15
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0ARDAVAN KEYHAN CPA
ReturnHeader/ReturnTs02014-05-15T13:32:44-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02013-01-01
ReturnHeader/TaxPeriodEndDt02013-12-31
ReturnHeader/TaxYr02013

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings

Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2025Detailed filing. Detailed filing data is available for this year.$8.98$0.25$8.73$0.18$0.39$0.21
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.24$8.90$0.16$0.33$0.18
2023XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.13$0.25$8.88$0.25$0.26$0.01
2022XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.07$0.18$8.89$0.13$0.27$0.14
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.26$0.19$9.08$0.29$0.24$0.05
2020XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$9.15$0.19$8.96$1.17$0.30$0.87
2019XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.33$0.03$8.30$0.67$0.46$0.20
2018XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$8.15$0.03$8.12$0.69$0.47$0.22
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.94$0.04$7.90$0.88$0.56$0.32
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$7.72$0.14$7.58$0.69$0.66$0.02
2015Detailed filing. Detailed filing data is available for this year.$7.72$0.16$7.56$0.96$0.57$0.39
2014Detailed filing. Detailed filing data is available for this year.$7.38$0.28$7.10$0.93$0.58$0.35
2013Detailed filing. Detailed filing data is available for this year.$7.02$0.16$6.86$1.02$0.59$0.43
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.59$0.16$6.43$0.57
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$6.07$0.15$5.93$0.30